Company / EPS (Basic)
CHAMPIONS ONCOLOGY, INC. EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.54
FY2025
5-year range
-$0.54 / $0.04
FY2021-FY2025
Trend
-38.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) has fluctuated over the past 8 years, ranging from $-2.20 in FY2016 to $0.04 in FY2023.
Based on SEC 10-K filings.
-0.54 in FY2025.
Declined from $0.04 to $-0.54 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) decreased 38.5% year-over-year.
- Peak eps (basic) was recorded in FY2023.
- Lowest eps (basic) in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.54 | -38.5% |
| FY2024 | -$0.39 | -1075.0% |
| FY2023 | $0.04 | +33.3% |
| FY2022 | $0.03 | +116.7% |
| FY2021 | -$0.18 | -1900.0% |
| FY2020 | $0.01 | +107.7% |
| FY2019 | -$0.13 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | -$2.20 | -1900.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026